[go: up one dir, main page]

NO960062D0 - Farmasöytiske preparater for tungt opplöselige aktive midler - Google Patents

Farmasöytiske preparater for tungt opplöselige aktive midler

Info

Publication number
NO960062D0
NO960062D0 NO960062A NO960062A NO960062D0 NO 960062 D0 NO960062 D0 NO 960062D0 NO 960062 A NO960062 A NO 960062A NO 960062 A NO960062 A NO 960062A NO 960062 D0 NO960062 D0 NO 960062D0
Authority
NO
Norway
Prior art keywords
active agent
component
active agents
pharmaceutical preparations
soluble active
Prior art date
Application number
NO960062A
Other languages
English (en)
Other versions
NO306929B1 (no
NO960062L (no
Inventor
Ulrich Posanski
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6492300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO960062(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NO960062D0 publication Critical patent/NO960062D0/no
Publication of NO960062L publication Critical patent/NO960062L/no
Publication of NO306929B1 publication Critical patent/NO306929B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO960062A 1993-07-08 1996-01-05 Farmasoeytiske preparater for opploeseliggjoering av cyklosporiner NO306929B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4322826A DE4322826A1 (de) 1993-07-08 1993-07-08 Pharmazeutisches Präparat
PCT/EP1994/002238 WO1995001785A1 (de) 1993-07-08 1994-07-08 Pharmazeutische präparate für schwerlösliche wirkstoffe

Publications (3)

Publication Number Publication Date
NO960062D0 true NO960062D0 (no) 1996-01-05
NO960062L NO960062L (no) 1996-01-05
NO306929B1 NO306929B1 (no) 2000-01-17

Family

ID=6492300

Family Applications (2)

Application Number Title Priority Date Filing Date
NO960069A NO306763B1 (no) 1993-07-08 1996-01-05 Farmasöytiske sammensetninger for opplöseliggjöring av tungt opplöselige virkestoffer
NO960062A NO306929B1 (no) 1993-07-08 1996-01-05 Farmasoeytiske preparater for opploeseliggjoering av cyklosporiner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO960069A NO306763B1 (no) 1993-07-08 1996-01-05 Farmasöytiske sammensetninger for opplöseliggjöring av tungt opplöselige virkestoffer

Country Status (24)

Country Link
EP (3) EP0710104B1 (no)
JP (4) JPH08512303A (no)
KR (2) KR100359044B1 (no)
CN (2) CN1313154C (no)
AT (3) ATE261720T1 (no)
AU (2) AU689486B2 (no)
BR (1) BR9407002A (no)
CA (2) CA2166204C (no)
CY (2) CY2308B1 (no)
CZ (1) CZ291401B6 (no)
DE (6) DE4322826A1 (no)
DK (3) DK1092429T3 (no)
ES (3) ES2159564T3 (no)
FI (2) FI116197B (no)
GR (1) GR3036571T3 (no)
HU (2) HU228127B1 (no)
NO (2) NO306763B1 (no)
NZ (2) NZ269552A (no)
PL (1) PL179717B1 (no)
PT (2) PT710103E (no)
RU (1) RU2140291C1 (no)
SI (1) SI1092429T1 (no)
SK (1) SK280615B6 (no)
WO (2) WO1995001786A1 (no)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
US6413536B1 (en) * 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US6696413B2 (en) * 1995-06-16 2004-02-24 Hexal Ag Pharmaceutical preparation with cyclosporin A
BE1009856A5 (fr) 1995-07-14 1997-10-07 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule.
GB2317562B (en) * 1995-07-20 1999-08-18 Danbiosyst Uk Lipid vehicle drug delivery composition containing vitamin E
GB9514878D0 (en) * 1995-07-20 1995-09-20 Danbiosyst Uk Vitamin E as a solubilizer for drugs contained in lipid vehicles
US5597582A (en) * 1995-09-12 1997-01-28 Sanofi Oral gel capsule formulation of 1,2,4-benzotriazine oxides
DE19544507B4 (de) * 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
CN1259053A (zh) * 1997-04-11 2000-07-05 藤泽药品工业株式会社 药物组合物
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers
NZ512599A (en) 1998-12-30 2003-10-31 Dexcel Ltd Formulation for cyclosporin administration featuring a hydrophilic solvent and a surfactant with a HLB of less than 5
EP1221947B1 (en) * 1999-10-01 2004-12-08 Natco Pharma Limited Soft gel capsule resistant to gastric juices
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
WO2002041892A1 (en) * 2000-11-24 2002-05-30 Yamanouchi Pharmaceutical Co., Ltd. Water-soluble liquid internal medicine
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
UA79766C2 (en) 2001-12-14 2007-07-25 Yahotech Ag Pharmaceutical formulation comprising cyclosporin and use thereof
RU2217170C2 (ru) * 2002-02-08 2003-11-27 Мельников Глеб Евгеньевич Дезинфицирующее средство
RU2217169C2 (ru) * 2002-02-08 2003-11-27 Мельников Глеб Евгеньевич Дезинфицирующее средство
KR100533458B1 (ko) * 2002-07-20 2005-12-07 대화제약 주식회사 파클리탁셀의 가용화용 조성물 및 그의 제조 방법
GB2391473B (en) * 2002-08-02 2004-07-07 Satishchandra Punambhai Patel Pharmaceutical compositions
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
EP1603560A1 (en) 2003-02-06 2005-12-14 Cipla Ltd. Topical immunotherapy and compositions for use therein
JPWO2004073692A1 (ja) * 2003-02-18 2006-06-01 山下　伸二 難水溶性薬物のハードカプセル剤
CN1826100B (zh) * 2003-07-17 2010-12-22 旗帜药物胶囊公司 控释制剂
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
GB0425255D0 (en) * 2004-11-16 2004-12-15 Novartis Ag Pharmaceutical composition
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US20070196465A1 (en) * 2005-07-28 2007-08-23 George Bobotas Treatment with dihydropyridine calcium channel blockers and omega-3 fatty acids and a combination product thereof
GB0526419D0 (en) * 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
US8337883B2 (en) 2006-11-03 2012-12-25 Durect Corporation Transdermal delivery systems
EP1952807A1 (en) * 2007-01-24 2008-08-06 LEK Pharmaceuticals D.D. Sirolimus formulation
ITMI20070720A1 (it) * 2007-04-06 2008-10-07 Monteresearch Srl Composizioni orali contenenti tacrolimus in forma amorfa
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
KR20120061081A (ko) * 2009-04-10 2012-06-12 하이얀 치 새로운 노화 방지 물질 및 그 확인 방법
DK4378443T3 (da) 2009-10-12 2025-08-18 Boehringer Ingelheim Vetmedica Gmbh Beholdere til sammensætninger, der omfatter meloxicam
SG183846A1 (en) 2010-03-03 2012-10-30 Boehringer Ingelheim Vetmed Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
JP5970224B2 (ja) 2011-07-11 2016-08-17 株式会社日本自動車部品総合研究所 内燃機関用のスパークプラグ
KR20140071913A (ko) * 2012-12-04 2014-06-12 삼성정밀화학 주식회사 식품 조성물 및 이를 포함하는 연질 캡슐
CN106211758B (zh) * 2013-04-09 2021-03-23 北京强新生物科技有限公司 2-乙酰基萘并[2,3-b]呋喃-4,9-二酮用于治疗癌症的用途
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
EA036036B1 (ru) * 2014-11-07 2020-09-16 Сигмойд Фарма Лимитед Композиции, содержащие циклоспорин
CN105828827A (zh) 2014-11-21 2016-08-03 杭州领业医药科技有限公司 一种含他克莫司的药物组合物及其制备方法
WO2016205423A2 (en) 2015-06-15 2016-12-22 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
EP3445362B1 (en) 2016-04-20 2021-09-22 VeroScience LLC Composition and method for treating metabolic disorders
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
EP3697418B1 (en) * 2017-10-18 2024-07-24 VeroScience LLC Improved bromocriptine formulations
KR102833016B1 (ko) * 2018-03-14 2025-07-14 칸디 테라퓨틱스 리미티드 이중 nk-1/nk-3 수용체 길항제를 포함하는 신규한 제약 제제
CN108853044B (zh) * 2018-07-06 2020-11-06 郑州明泽医药科技有限公司 一种硝苯地平缓释片及其制备方法
US12150945B2 (en) 2018-07-20 2024-11-26 Lipocine Inc. Liver disease
CA3149877A1 (en) 2019-09-23 2021-04-01 Anthony H. Cincotta Method for inducing tumor regression
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
WO2022131656A1 (ko) * 2020-12-15 2022-06-23 윤관식 알칼로이드 함유 수용성 유화 조성물
KR102712501B1 (ko) * 2021-02-26 2024-10-02 윤관식 알칼로이드 함유 수용성 유화 조성물
KR102524312B1 (ko) * 2020-12-15 2023-04-21 윤관식 엑디스테로이드 함유 수용성 유화 조성물
KR102583074B1 (ko) * 2021-01-25 2023-09-25 윤관식 천연 폴리페놀 화합물 함유 수용성 유화 조성물
JP2024503402A (ja) 2021-01-12 2024-01-25 デュレクト コーポレーション 徐放性薬物送達システム及び関連の方法
CN113041236B (zh) * 2021-03-23 2023-03-10 广州新济药业科技有限公司 氟比洛芬巴布剂及其制备方法
WO2024248510A1 (ko) * 2023-06-02 2024-12-05 주식회사 지엔티파마 안정성 및 용출률이 개선된 크리스데살라진 함유 약학 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1132518A (en) * 1965-02-18 1968-11-06 Richardson Merrell Inc Medicinal composition
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
ES2033086T3 (es) * 1988-01-29 1993-03-01 Sankyo Company Limited Un procedimiento para la preparacion de una composicion farmaceutica.
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
EP0448091B1 (en) * 1990-03-23 1998-08-05 The Green Cross Corporation Pharmaceutical composition containing slightly water-soluble drug
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
JPH0525037A (ja) * 1991-07-01 1993-02-02 Upjohn Co:The 経口投与酵素感受性腸溶製剤
RU2053764C1 (ru) * 1991-07-19 1996-02-10 Эгиш Дьедьсердьяр Мягкая желатиновая капсула и способ ее получения
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat

Also Published As

Publication number Publication date
DE4494850D2 (de) 1996-08-22
PT1092429E (pt) 2004-08-31
SK280615B6 (sk) 2000-05-16
CZ291401B6 (cs) 2003-03-12
EP1092429A1 (de) 2001-04-18
FI960032A0 (fi) 1996-01-03
DE59409787D1 (de) 2001-07-19
HU9503868D0 (en) 1996-02-28
FI116197B (fi) 2005-10-14
CY2308B1 (en) 2003-11-14
NO960069L (no) 1996-01-05
NO306929B1 (no) 2000-01-17
NZ269808A (en) 1996-07-26
CZ4596A3 (en) 1996-04-17
HU9503965D0 (en) 1996-03-28
SK1996A3 (en) 1997-04-09
RU2140291C1 (ru) 1999-10-27
KR100359044B1 (ko) 2003-02-05
WO1995001786A1 (de) 1995-01-19
PT710103E (pt) 2001-11-30
CN1121853C (zh) 2003-09-24
ATE261720T1 (de) 2004-04-15
CA2166204C (en) 2009-04-14
DE4494851D2 (de) 1996-12-19
DK1092429T3 (da) 2004-07-19
ES2124420T3 (es) 1999-02-01
JPH08512303A (ja) 1996-12-24
CN1496743A (zh) 2004-05-19
ATE201985T1 (de) 2001-06-15
DK0710103T3 (da) 2001-09-24
JP2009138008A (ja) 2009-06-25
EP0710104A1 (de) 1996-05-08
SI1092429T1 (en) 2004-08-31
FI960032L (fi) 1996-02-09
AU7385094A (en) 1995-02-06
FI960042L (fi) 1996-01-04
EP0710103A1 (de) 1996-05-08
CY2604B2 (en) 2010-04-28
CA2164100A1 (en) 1995-01-19
PL179717B1 (pl) 2000-10-31
CN1128495A (zh) 1996-08-07
PL312255A1 (en) 1996-04-01
CA2166204A1 (en) 1995-01-19
JPH08512301A (ja) 1996-12-24
HU223073B1 (hu) 2004-03-01
EP0710103B1 (de) 2001-06-13
GR3036571T3 (en) 2001-12-31
ES2159564T3 (es) 2001-10-16
KR100386533B1 (ko) 2003-08-21
ATE172876T1 (de) 1998-11-15
DK0710104T3 (da) 1999-07-19
AU7345794A (en) 1995-02-06
AU689486B2 (en) 1998-04-02
HUT73427A (en) 1996-07-29
WO1995001785A1 (de) 1995-01-19
FI960042A0 (fi) 1996-01-04
DE4322826A1 (de) 1995-01-12
DE59407239D1 (de) 1998-12-10
HU228127B1 (en) 2012-12-28
CN1313154C (zh) 2007-05-02
HUT73661A (en) 1996-09-30
EP1092429B1 (de) 2004-03-17
NO306763B1 (no) 1999-12-20
EP0710104B1 (de) 1998-11-04
FI116714B (fi) 2006-02-15
BR9407002A (pt) 1996-09-03
NO960062L (no) 1996-01-05
JP2011153150A (ja) 2011-08-11
NZ269552A (en) 1996-07-26
DE59410365D1 (de) 2004-04-22
ES2218046T3 (es) 2004-11-16
NO960069D0 (no) 1996-01-05

Similar Documents

Publication Publication Date Title
NO960062D0 (no) Farmasöytiske preparater for tungt opplöselige aktive midler
BR9509496A (pt) Composições farmacêuticas
ATE265847T1 (de) Selbstemulgierbare formulierung enthaltend lipophile verbindungen

Legal Events

Date Code Title Description
MK1K Patent expired